Roche Korea to commit cooperation for returned stock problems.

Published: 2005-10-10 07:00:00

Updated: 2005-10-10 07:00:00

The Seoul Pharmaceutical Association (SPA) met with Roche Korea on Sept. 4 to ask for the cooperation of returned stock problems, and Roche indicated that unopened stocks be returned at any time but the opened stocks would be acceptive only during the 2nd chance of the returned stocks implemented...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK